Coronavirus (COVID-19) vaccination rates for people aged 18 years and over in England. Estimates by socio-demographic characteristic, region and local authority.

Vaccinations in London Between 8 December 2020 and 15 September 2021 5,838,305 1st doses and 5,232,885 2nd doses have been administered to London residents. Differences in vaccine roll out between London and the Rest of England London Rest of England Priority Group Vaccinations given Percentage vaccinated Vaccinations given Percentage vaccinated Group 1 Older Adult Care Home Residents 21,883 95% 275,964 96% Older Adult Care Home Staff 29,405 85% 381,637 88% Group 2 80+ years 251,021 83% 2,368,284 93% Health Care Worker 174,944 99% 1,139,243 100%* Group 3 75 - 79 years 177,665 90% 1,796,408 99% Group 4 70 - 74 years 252,609 90% 2,454,381 97% Clinically Extremely Vulnerable 278,967 88% 1,850,485 95% Group 5 65 - 69 years 285,768 90% 2,381,250 97% Group 6 At Risk or Carer (Under 65) 983,379 78% 6,093,082 88% Younger Adult Care Home Residents 3,822 92% 30,321 93% Group 7 60 - 64 years 373,327 92% 2,748,412 98% Group 8 55 - 59 years 465,276 91% 3,152,412 97% Group 9 50 - 54 years 510,132 90% 3,141,219 95% Data as at 15 September 2021 for age based groups and as at 12 September 2021 for non-age based groups * The number who have received their first dose exceeds the latest official estimate of the population for this group There is considerable uncertainty in the population denominators used to calculate the percentage vaccinated. Comparing implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following datasets can be used to estimate vaccine uptake by age group for London: ONS 2020 mid-year estimates (MYE). This is the population estimate used for age groups throughout the rest of the analysis. Number of people ages 18 and over on the National Immunisation Management Service (NIMS) ONS Public Health Data Asset (PHDA) dataset. This is a linked dataset combining the 2011 Census, the General Practice Extraction Service (GPES) data for pandemic planning and research and the Hospital Episode Statistics (HES). This data covers a subset of the population. Vaccine roll out in London by Ethnic Group Understanding how vaccine uptake varies across different ethnic groups in London is complicated by two issues: Ethnicity information for recipients is unavailable for a very large number of the vaccinations that have been delivered. As a result, estimates of vaccine uptake by ethnic group are highly sensitive to the assumptions about and treatment of the Unknown group in calculations of rates. For vaccinations given to people aged 50 and over in London nearly 10% do not have ethnicity information available, The accuracy of available population denominators by ethnic group is limited. Because ethnicity information is not captured in official estimates of births, deaths, and migration, the available population denominators typically rely on projecting forward patterns captured in the 2011 Census. Subsequent changes to these patterns, particularly with respect to international migration, leads to increasing uncertainty in the accuracy of denominators sources as we move further away from 2011. Comparing estimated population sizes and implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following population estimates are available by Ethnic group for London:

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

These data describe pneumococcal polysaccharide vaccine (PPV) uptake for the survey year, for those aged 65 years and over.RationaleVaccination coverage is the best indicator of the level of protection a population will have against vaccine preventable communicable diseases. Coverage is closely related to levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise. Pneumococcal disease is a significant cause of morbidity and mortality. Certain groups are at risk for severe pneumococcal disease, these include young children, the elderly and people who are in clinical risk groups2. Pneumococcal infections can be non invasive such as bronchitis, otitis media or invasive such as septicaemia, pneumonia, meningitis. Cases of invasive pneumococcal infection usually peak in the winter during December and January. The pneumococcal polysaccharide vaccine (PPV) protects against 23 types of Streptococcus pneumoniae bacterium. It is thought that the PPV is around 50 percent to 70 percent effective at preventing more serious types of invasive pneumococcal infection2.Since 1992 the 23 valent PPV has been recommended for people in the clinical risk groups and since 2003, the PPV vaccination programme has expanded to include immunisation to all those aged 65 years and over in England1This indicator was judged to be a valid and an important measure of public health and was therefore included in the public health outcomes framework. Inclusion of these indicators will encourage the continued prioritisation and evaluation and the effectiveness of the PPV vaccination programme and give an indication of uptake at an upper tier Local Authority level. The vaccination surveys measure the proportion of eligible people that have received PPV at any time and the proportion that received PPV during the previous year, providing an opportunity to assess the delivery of the immunisation programme11 Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2013 to March 2014 [online]. 2015 [cited 2015 Mar]. Available from URL: https://www.gov.uk/government/publications/pneumococcal-polysaccharide-vaccine-ppv-vaccine-coverage-estimates 2 Pneumococcal infections, NHS Choices [online]. 2013 [cited 2013 Dec]. Available from URL: http://www.nhs.uk/conditions/vaccinations/pages/pneumococcal-vaccination.aspxDefinition of numeratorUKHSA provided UTLA level data. Clinical commissioning group (CCG) data is available from https://www.gov.uk/government/collections/vaccine-uptake#ppv-vaccine-uptakeDefinition of denominatorNumber of adults aged 65 years and over. Data from 2013 to 2014 are now available at source at a local authority level. Data prior to 2013 to 2014 were collected at a PCT level and converted to LA level for inclusion in PHOF using the criteria as defined below:Denominators for local authorities are estimated from denominators for PCTs. Denominators for PCTs include all people registered with practices accountable to the PCT, and no data are available to provide resident-based figures. Denominators for local authorities are estimated as follows: (For local authorities that have exactly the same boundary as a PCT, the PCT figure is used as it is the only estimate available for the residents of the PCT and local authority. For local authorities whose boundary is contained wholly within a single PCT, but is not equal to the whole PCT, the LA denominator is estimated as a proportion of the PCT figure, with the exceptions of Isles of Scilly, City of London, Rutland, Cornwall, Hackney and Leicestershire (see below). For local authorities whose boundaries include all or part of more than one PCT, the local authority denominator is estimated by aggregating the appropriate proportions of the denominators for the PCTs whose boundaries include part of the local authority. The appropriate proportions in cases ii and iii are defined according to the resident population (in the appropriate age group) in the calendar year overlapping most of the period of the indicator value (or the most recent available): resident population by Lower Layer Super Output Area were extracted and used to calculate the population resident in every LA PCT overlapping block.To calculate the denominator, each LA PCT overlap is calculated as a proportion of the PCT resident population, and then multiplied by the denominator for the PCT. A LA may overlap several PCTs: the appropriate portions of all the PCTs’ denominators are aggregated to give the denominator estimate for the LA. Expressed as an equation the denominator is calculated as follows: DenominatorLA = ∑ (DenominatorPCT × n/N) summed over all PCTs overlapping the LA where: DenominatorLA = Estimated denominator in the LA n = Population resident in the LA-PCT overlapping block N = Population resident in the PCT DenominatorPCT = Denominator in the PCT For Isles of Scilly, City of London and Rutland, no indicator data are presented (prior to 2013 to 2014), as the local authority makes up a very small proportion of the PCT, and estimates for the LAs based on the PCT figures are unlikely to be representative as they are swamped by the much larger local authority within the same PCT. The estimates for Cornwall, Hackney and Leicestershire local authorities are combined data for Cornwall and Isles of Scilly, City of London and Hackney, and Leicestershire and Rutland respectively in order to ensure that all valid PCT data are included in the England total.Denominators for Cornwall and Isles of Scilly, City of London and Hackney, and Leicestershire and Rutland are not combined for the 2019 to 2020 annual local authority level data."CaveatsThe pneumococcal vaccine uptake collection is a snapshot of GP patients vaccinated currently registered at the time of data extraction. The proportion of GP practices who provided data for the surveys are available from the uptake reports. Data will exclude patients who have received the vaccine but have subsequently died, patients who have since moved, or patients that are vaccinated but have not had their electronic patient record updated by the time of data extraction. Data for local authorities prior to 2013 to 2014 have been estimated from registered PCT level indicators. While the majority of patients registered with practices accountable to a PCT tend to be resident within that PCT, there are, in some PCTs, significant differences between their resident and registered populations. Therefore the estimates for LAs may not always accurately reflect the resident population of the local authority (LA). Please note that the PCT response rate should be checked for data completeness as this will have a knock on effect to the LA values.

Flu vaccine uptake (%) in adults aged 65 and over, who received the flu vaccination between 1st September to the end of February as recorded in the GP record. The February collection has been adopted for our end of season figures from 2017 to 2018. All previous data is the same definitions but until the end of January rather than February to consider data returning from outside the practice and later in practice vaccinations.RationaleInfluenza (also known as Flu) is a highly infectious viral illness spread by droplet infection. The flu vaccination is offered to people who are at greater risk of developing serious complications if they catch the flu. The seasonal influenza programme for England is set out in the Annual Flu Letter. Both the flu letter and the flu plan have the support of the Chief Medical Officer (CMO), Chief Pharmaceutical Officer (CPhO), and Director of Nursing.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine-preventable communicable diseases. Immunisation is one of the most effective healthcare interventions available, and flu vaccines can prevent illness and hospital admissions among these groups of people. Increasing the uptake of the flu vaccine among these high-risk groups should also contribute to easing winter pressure on primary care services and hospital admissions. Coverage is closely related to levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The UK Health Security Agency (UKHSA) will continue to provide expert advice and monitoring of public health, including immunisation. NHS England now has responsibility for commissioning the flu programme, and GPs continue to play a key role. NHS England teams will ensure that robust plans are in place locally and that high vaccination uptake levels are reached in the clinical risk groups. For more information, see the Green Book chapter 19 on Influenza.The Annual Flu Letter sets out the national vaccine uptake ambitions each year. In 2021 to 2022, the national ambition was to achieve at least 85 percent vaccine uptake in those aged 65 and over. Prior to this, the national vaccine uptake ambition was 75 percent, in line with WHO targets.Definition of numeratorNumerator is the number of vaccinations administered during the influenza season between 1st September and the end of February.Definition of denominatorDenominator is the GP registered population on the date of extraction including patients who have been offered the vaccine but refused it, as the uptake rate is measured against the overall eligible population. For more detailed information please see the user guide, available to view and download from https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptakeCaveatsRead codes are primarily used for data collection purposes to extract vaccine uptake data for patients who fall into one or more of the designated clinical risk groups. The codes identify individuals at risk, and therefore eligible for flu vaccination. However, it is important to note that there may be some individuals with conditions not specified in the recommended risk groups for vaccination, who may be offered influenza vaccine by their GP based on clinical judgement and according to advice contained in the flu letter and Green Book, and thus are likely to fall outside the listed Read codes. Therefore, this data should not be used for GP payment purposes.

Shingles vaccine coverage for adults of GP registered population turning 71 between 1 April to 31 March, and vaccinated by the following end of June.RationaleThe shingles vaccination programme was introduced to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals’ pre-existing VZV immunity. The shingles vaccine stimulates individual pre-existing immunity, which cannot be acquired naturally, so immunisation is required for protection.In 2010, the UK’s Joint Committee on Vaccination and Immunisation (JCVI) recommended that a herpes zoster (shingles) vaccination programme should be introduced for adults aged 70 years, with a catch-up programme for those aged 71 to 79 years.In April 2017, eligibility criteria for the shingles vaccination were revised so that adults become eligible for the routine programme on their 70th birthday and remain eligible until their 80th birthday. Following this change, from 2018 to 2019, vaccine coverage is measured in those aged 71 and is calculated as the total number of patients who turned 71 between 1 April and 31 March, and were vaccinated by the end of June, as a proportion of the number of patients that turned 71 years old between 1 April and 31 March.Prior to this (2013 to 2014 to 2017 to 2018), the vaccine was routinely offered to adults aged 70 years on 1 September of the programme year. Vaccine coverage was calculated as the total number of patients aged 70 on 1 September who had ever received the vaccination (numerator) as a proportion of the number of patients registered aged 70 years on 1 September (denominator) as of the following August.Due to the changes in the vaccination coverage collection described, data for this indicator are not comparable to the previous shingles indicator D06c: shingles vaccination coverage among 70-year-olds, available from 2013 to 2014 to 2017 to 2018.Reference:Shingles (herpes zoster): the green book, chapter 28.Definition of numeratorNumber of patients registered with a GP practice with 71st birthday within the financial year that received a shingles vaccination by the end of the June. The age and timing of the extraction for the numerator are different to the numerator describe in submissions prior to 2018 and 2019 in the D06c Population vaccination coverage: Shingles (70 years old) indicator. The numerators from these two indicators should not be compared.Definition of denominatorNumber of patients registered with a GP practice in each LA whose 71st birthday is within the financial year. The age and timing of the extraction for the denominator are different to the denominator describe in submissions prior to 2018 and 2019 in the D06c Population vaccination coverage: Shingles (70 years old) indicator. The denominators from these two indicators should not be compared.CaveatsAggregated GP practice level shingles vaccine coverage data is automatically uploaded via participating GP IT suppliers to the ImmForm website on a quarterly basis, and these data in turn are aggregated to LA level. The proportion of participating practices is currently at least 95 percentof all GP practices in England. Therefore, number of registered patients aged 71 years in each LA is based on participating practices only. Where less than 100 percent of practices in an LA participate the number of registered patients will not represent the true total in that LA and therefore vaccine coverage may not be truly representative of that LA.

Additional file 1: Supplement Figure 1. Bar chart depicting the number of reported datasets per region of the UK. * represents where some specific trial site locations were unavailable within this region

The COVID-19 Vaccine Opinions Survey (VOS) is a follow up to the Opinions and Lifestyle Survey (OPN) (held at the UK Data Archive under SN 8635), and questions those specifically who reported hesitancy towards the coronavirus (COVID-19) vaccine. The survey has been commissioned by the Department of Health and Social Care (DHSC) to identify changes in attitudes towards the COVID-19 vaccine, and the factors and interventions that may have influenced initially hesitant people's decision to get a vaccine.

Survey content for this study has been developed in consultation with DHSC, Cabinet Office and National Health Service (NHS) England. The survey was carried out using an online survey by the Office for National Statistics. The sample was based on 4,272 adults in England who took part in the OPN (over the period 13 January to 8 August 2021), specifically those who indicated hesitancy or uncertainty towards getting or who had refused to get the COVID-19 vaccine. These respondents had previously provided consent to be re-contacted for future research. The responding sample contained 2,482 individuals, representing a 58 per cent response rate. This is a one-off survey and currently there are no plans to carry out a second wave.

Following Edward Jenner's development of the smallpox vaccine in 1796, the death rate due to smallpox in England and Wales dropped significantly. Although Jenner's work was published in 1797, it would take over half a century for the British government to make vaccination compulsory for all infants. Between 1847 and 1853, when vaccination was optional, children under the age of five years had, by far, the largest number of deaths; the total death rate was 1.6 thousand deaths per million people, which was more than five times the overall death rate due to smallpox. When compulsory vaccination was introduced, this helped bring the smallpox death rate in this age group down by over fifty percent between 1854 and 1871. When compulsory vaccination was enforced with penalties in the wake of the Great Pandemic of the 1870s, the smallpox death rate among children under the age of five dropped to approximately fifteen percent of its optional vaccination level. Increase among adults Along with the youngest age group, children aged five to ten years also saw their death rates decrease by roughly two thirds, and the death rate among those aged ten to 15 declined by just under one third during this time. It was among adults, aged above 15 years, where the introduction of mandatory vaccination had an adverse effect on their death rates; increasing by fifty percent among young adults, and almost doubling among those aged 25 to 45. The reason for this was because, contrary to Jenner's theory, vaccination did not guarantee lifelong protection, and immunization gradually wore off making vaccinated people susceptible to the virus again in adulthood. There was some decline in the smallpox death rates among adults throughout the 1870s and 1880s, as revaccination became more common, and the enforced vaccination of children prevented smallpox from spreading as rapidly as in the pre-vaccination era. Overall trends While the introduction of mandatory vaccination saw the number of smallpox deaths increase for age groups above 15 years, the overall rate among all ages decreased, due to the huge drop in deaths among infants and children. The smallpox death rate dropped by over one quarter when compulsory vaccination was introduced, and it then fell to just over one third of it's optional-vaccination level when these measures were enforced. The development of the smallpox vaccine and the implementation of mandatory vaccination led to the eradication of the disease in Britain by 1934, and contributed greatly to the demographic developments of the twentieth century, such as the declines in fertility rate and birth rate, and the increase in life expectancy.

This data originates from the Public Health Outcomes tool currently presents data for available indicators for upper tier local authority levels, collated by Public Health England (PHE). The data currently published here are the baselines for the Public Health Outcomes Framework, together with more recent data where these are available. The baseline period is 2010 or equivalent, unless these data are unavailable or not deemed to be of sufficient quality. The first data were published in this tool as an official statistics release in November 2012. Future official statistics updates will be published as part of a quarterly update cycle in August, November, February and May. The definition, rationale, source information, and methodology for each indicator can be found within the spreadsheet. Data included in the spreadsheet: 0.1i - Healthy life expectancy at birth0.1ii - Life Expectancy at 650.1ii - Life Expectancy at birth0.2i - Slope index of inequality in life expectancy at birth based on national deprivation deciles within England0.2ii - Number of upper tier local authorities for which the local slope index of inequality in life expectancy (as defined in 0.2iii) has decreased0.2iii - Slope index of inequality in life expectancy at birth within English local authorities, based on local deprivation deciles within each area0.2iv - Gap in life expectancy at birth between each local authority and England as a whole0.2v - Slope index of inequality in healthy life expectancy at birth based on national deprivation deciles within England0.2vii - Slope index of inequality in life expectancy at birth within English regions, based on regional deprivation deciles within each area1.01i - Children in poverty (all dependent children under 20)1.01ii - Children in poverty (under 16s)1.02i - School Readiness: The percentage of children achieving a good level of development at the end of reception1.02i - School Readiness: The percentage of children with free school meal status achieving a good level of development at the end of reception1.02ii - School Readiness: The percentage of Year 1 pupils achieving the expected level in the phonics screening check1.02ii - School Readiness: The percentage of Year 1 pupils with free school meal status achieving the expected level in the phonics screening check1.03 - Pupil absence1.04 - First time entrants to the youth justice system1.05 - 16-18 year olds not in education employment or training1.06i - Adults with a learning disability who live in stable and appropriate accommodation1.06ii - % of adults in contact with secondary mental health services who live in stable and appropriate accommodation1.07 - People in prison who have a mental illness or a significant mental illness1.08i - Gap in the employment rate between those with a long-term health condition and the overall employment rate1.08ii - Gap in the employment rate between those with a learning disability and the overall employment rate1.08iii - Gap in the employment rate for those in contact with secondary mental health services and the overall employment rate1.09i - Sickness absence - The percentage of employees who had at least one day off in the previous week1.09ii - Sickness absence - The percent of working days lost due to sickness absence1.10 - Killed and seriously injured (KSI) casualties on England's roads1.11 - Domestic Abuse1.12i - Violent crime (including sexual violence) - hospital admissions for violence1.12ii - Violent crime (including sexual violence) - violence offences per 1,000 population1.12iii- Violent crime (including sexual violence) - Rate of sexual offences per 1,000 population1.13i - Re-offending levels - percentage of offenders who re-offend1.13ii - Re-offending levels - average number of re-offences per offender1.14i - The rate of complaints about noise1.14ii - The percentage of the population exposed to road, rail and air transport noise of 65dB(A) or more, during the daytime1.14iii - The percentage of the population exposed to road, rail and air transport noise of 55 dB(A) or more during the night-time1.15i - Statutory homelessness - homelessness acceptances1.15ii - Statutory homelessness - households in temporary accommodation1.16 - Utilisation of outdoor space for exercise/health reasons1.17 - Fuel Poverty1.18i - Social Isolation: % of adult social care users who have as much social contact as they would like1.18ii - Social Isolation: % of adult carers who have as much social contact as they would like1.19i - Older people's perception of community safety - safe in local area during the day1.19ii - Older people's perception of community safety - safe in local area after dark1.19iii - Older people's perception of community safety - safe in own home at night2.01 - Low birth weight of term babies2.02i - Breastfeeding - Breastfeeding initiation2.02ii - Breastfeeding - Breastfeeding prevalence at 6-8 weeks after birth2.03 - Smoking status at time of delivery2.04 - Under 18 conceptions2.04 - Under 18 conceptions: conceptions in those aged under 162.06i - Excess weight in 4-5 and 10-11 year olds - 4-5 year olds2.06ii - Excess weight in 4-5 and 10-11 year olds - 10-11 year olds2.07i - Hospital admissions caused by unintentional and deliberate injuries in children (aged 0-14 years)2.07i - Hospital admissions caused by unintentional and deliberate injuries in children (aged 0-4 years)2.07ii - Hospital admissions caused by unintentional and deliberate injuries in young people (aged 15-24)2.08 - Emotional well-being of looked after children2.09i - Smoking prevalence at age 15 - current smokers (WAY survey)2.09ii - Smoking prevalence at age 15 - regular smokers (WAY survey)2.09iii - Smoking prevalence at age 15 - occasional smokers (WAY survey)2.09iv - Smoking prevalence at age 15 years - regular smokers (SDD survey)2.09v - Smoking prevalence at age 15 years - occasional smokers (SDD survey)2.12 - Excess Weight in Adults2.13i - Percentage of physically active and inactive adults - active adults2.13ii - Percentage of physically active and inactive adults - inactive adults2.14 - Smoking Prevalence2.14 - Smoking prevalence - routine & manual2.15i - Successful completion of drug treatment - opiate users2.15ii - Successful completion of drug treatment - non-opiate users2.16 - People entering prison with substance dependence issues who are previously not known to community treatment2.17 - Recorded diabetes2.18 - Admission episodes for alcohol-related conditions - narrow definition2.19 - Cancer diagnosed at early stage (Experimental Statistics)2.20i - Cancer screening coverage - breast cancer2.20ii - Cancer screening coverage - cervical cancer2.21i - Antenatal infectious disease screening – HIV coverage2.21iii - Antenatal Sickle Cell and Thalassaemia Screening - coverage2.21iv - Newborn bloodspot screening - coverage2.21v - Newborn Hearing screening - Coverage2.21vii - Access to non-cancer screening programmes - diabetic retinopathy2.21viii - Abdominal Aortic Aneurysm Screening2.22iii - Cumulative % of the eligible population aged 40-74 offered an NHS Health Check2.22iv - Cumulative % of the eligible population aged 40-74 offered an NHS Health Check who received an NHS Health Check2.22v - Cumulative % of the eligible population aged 40-74 who received an NHS Health check2.23i - Self-reported well-being - people with a low satisfaction score2.23ii - Self-reported well-being - people with a low worthwhile score2.23iii - Self-reported well-being - people with a low happiness score2.23iv - Self-reported well-being - people with a high anxiety score2.23v - Average Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) score2.24i - Injuries due to falls in people aged 65 and over2.24ii - Injuries due to falls in people aged 65 and over - aged 65-792.24iii - Injuries due to falls in people aged 65 and over - aged 80+3.01 - Fraction of mortality attributable to particulate air pollution3.02 - Chlamydia detection rate (15-24 year olds)3.02 - Chlamydia detection rate (15-24 year olds)3.03i - Population vaccination coverage - Hepatitis B (1 year old)3.03i - Population vaccination coverage - Hepatitis B (2 years old)3.03iii - Population vaccination coverage - Dtap / IPV / Hib (1 year old)3.03iii - Population vaccination coverage - Dtap / IPV / Hib (2 years old)3.03iv - Population vaccination coverage - MenC3.03ix - Population vaccination coverage - MMR for one dose (5 years old)3.03v - Population vaccination coverage - PCV3.03vi - Population vaccination coverage - Hib / Men C booster (5 years)3.03vi - Population vaccination coverage - Hib / MenC booster (2 years old)3.03vii - Population vaccination coverage - PCV booster3.03viii - Population vaccination coverage - MMR for one dose (2 years old)3.03x - Population vaccination coverage - MMR for two doses (5 years old)3.03xii - Population vaccination coverage - HPV3.03xiii - Population vaccination coverage - PPV3.03xiv - Population vaccination coverage - Flu (aged 65+)3.03xv - Population vaccination coverage - Flu (at risk individuals)3.04 - People presenting with HIV at a late stage of infection3.05i - Treatment completion for TB3.05ii - Incidence of TB3.06 - NHS organisations with a board approved sustainable development management plan3.07 - Comprehensive, agreed inter-agency plans for responding to health protection incidents and emergencies4.01 - Infant mortality4.02 - Tooth decay in children aged 54.03 - Mortality rate from causes considered preventable4.04i - Under 75 mortality rate from all cardiovascular diseases4.04ii - Under 75 mortality rate from cardiovascular diseases considered preventable4.05i - Under 75 mortality rate from cancer4.05ii - Under 75 mortality rate from cancer considered preventable4.06i - Under 75 mortality rate from liver disease4.06ii - Under 75 mortality rate from liver disease considered preventable4.07i - Under 75 mortality rate from respiratory disease4.07ii - Under 75 mortality rate from respiratory disease considered preventable4.08 - Mortality